How much funding has Cambrian BioPharma raised?

Cambrian BioPharma has raised $183.0M in total funding, most recently a Venture Round.

Who are Cambrian BioPharma's investors?

Cambrian BioPharma's investors include Apollo, Alumni Ventures.

Where is Cambrian BioPharma headquartered?

Cambrian BioPharma is headquartered in New York City, New York, United States.

What industry is Cambrian BioPharma in?

Cambrian BioPharma operates in Biotech.

How many employees does Cambrian BioPharma have?

Cambrian BioPharma has 11-50 employees.

Cambrian BioPharma

Cambrian Bio | Catalyzing breakthroughs

New York City, United States · $183.0M raised

Biotech

Headquarters: New York City, New York
Employees: 11–50
Business Model: B2B Biotech
Website: cambrianbio.com

Total Funding: $183.0M
Last Round: $23.0M Venture RoundJan 2025
Rounds: 3

About

Cambrian Bio is a clinical-stage drug development company building medicines to treat and ultimately prevent age-related chronic diseases. The company partners with scientists to advance a portfolio of longevity-focused pipeline programs, leveraging repeatable development models to extend human healthspan.

Summary

Cambrian BioPharma is a Biotech company based in New York City, United States. It has raised $183.0M in total across 3 rounds, most recently a $23.0M Venture Round round in Jan 2025. Investors include Apollo and Alumni Ventures.

X (Twitter)